The Biotechnology Folio was developed for investors seeking aggressive capital growth with significant volatility.
The Biotechnology Folio consists of large companies that range from drug therapy providers to genetic testing services.
Biotechnology companies have improved agricultural output for developing nations, enhanced the nutrition of foods, and produced medicines to cure or treat many different diseases. Breakthroughs are occurring throughout the industry and demand for bio-tech companies to produce more and better products could continue as science helps people live longer.
Last Updated: April 22, 2014
Inception Date: April 05, 2000
Date Funded: August 28, 2009*
|Year to Date||10%||2.29%|
|Three year (Annualized)||34.55%||14.46%|
|Five Year (Annualized)||30.53%||19.88%|
Past performance is no guarantee of future results.
See how returns are calculated
* Returns reflect model performance from the Inception Date to the Date Funded, and funded performance since the Date Funded, if funded. Your returns may deviate significantly from the values displayed here, due to many factors, including how long after a strategy has been updated that you place orders to update your holdings.
(% of Folio)
|1||ACOR||acorda therapeutics inc||3.33%|
|2||ALKS||alkermes pls shr||3.33%|
|3||ALNY||alnylam pharmaceuticals inc||3.33%|
|4||ALXN||alexion pharmaceuticals inc||3.33%|
|6||BIIB||biogen idec inc||3.33%|
|7||BIO.B||bio rad labs inc cl b||3.33%|
|8||BMRN||biomarin pharmaceutical inc||3.33%|
|10||CLVS||clovis oncology inc com||3.33%|
|11||GEVA||synageva biopharma corporation new||3.33%|
|12||GILD||gilead sciences inc||3.34%|
|13||HALO||halozyme therapeutics inc||3.34%|
|14||IART||integra lifesciences hldgs cp new||3.34%|
|15||ICPT||intercept pharmaceuticals inc com||3.33%|
|17||INCY||incyte genomics, inc||3.33%|
|18||ISIS||isis pharmaceuticals inc||3.34%|
|19||LGND||ligand pharmaceuticals inc cl b||3.33%|
|23||MYGN||myriad genetics inc||3.33%|
|24||PBYI||puma biotechnology inc com||3.34%|
|25||QGEN||qiagen n v ord||3.33%|
|26||RARE||ultragenyx pharmaceutical inc com||3.33%|
|28||SGEN||seattle genetics inc||3.33%|
|30||VRTX||vertex pharmaceuticals inc||3.33%|
There are generally 30 securities in the Folio.
If the characteristics of the Folio have changed substantially, the securities included may change. Also, corporate actions, such as a merger, or other events may cause changes to the securities held at any time. Your returns may deviate significantly from the values displayed here, due to many factors, including how long after a Folio has been updated that you place orders to update your holdings.